統合失調症における口腔細菌叢と認知機能の関連を明らかに~唾液中の細菌叢の多様性と代謝機能経路がこの関連を支える生物学的手がかりとなる可能性~

ad

2025-12-01 東京科学大学

東京科学大学の研究チームは、統合失調症患者68名と健常対照32名の唾液16S rRNA解析を行い、口腔細菌叢の多様性と認知機能(WAIS-IV FSIQ)の間に正の関連があることを初めて体系的に示した。患者群では「細菌叢の多様性(特に豊富さ)」が高いほど認知機能が高い傾向が認められた。また、PICRUSt2による機能推定から、補因子・ビタミン代謝、エネルギー代謝、糖質代謝、アミノ酸代謝、糖鎖代謝など複数の代謝経路がこの関連に間接的に関与する可能性が示唆された。さらに、細菌属 Neisseria など11属が、認知機能と関連する推定機能経路と共変動することも明らかになった。本研究は、“腸―脳軸” に加えて “口腔―脳軸” の重要性を示す基盤データであり、今後、口腔ケアやプレ/プロバイオティクス介入が認知機能維持に有効かを検証する研究への道を拓く成果である。

統合失調症における口腔細菌叢と認知機能の関連を明らかに~唾液中の細菌叢の多様性と代謝機能経路がこの関連を支える生物学的手がかりとなる可能性~
図1. 統合失調症(SZ)と健常対照(HC)の口腔細菌叢の違い。

<関連情報>

統合失調症における認知障害と関連する口腔内微生物叢:構成とPICRUSt2予測機能経路 Oral Microbiota Associated With Cognitive Impairment in Schizophrenia: Composition and PICRUSt2-Predicted Functional Pathways

Takehiro Tamura, Yujin Ohsugi, Sayaka Katagiri, Ayako Kusano, Takehisa Handa, Peiya Lin, Anhao Liu, Keita Toyoshima, Shunsuke Takagi, Hiroki Shiwaku …
Schizophrenia Bulletin  Published:27 November 2025
DOI:https://doi.org/10.1093/schbul/sbaf212

Abstract

Background and Hypothesis

Cognitive impairment is a core disabling feature of schizophrenia (SZ). Changes in gut microbiota have been linked to cognitive dysfunction in SZ; however, changes in the oral microbiota in relation to immune dysregulation have only been recently reported, and their relevance to cognition remains unclear. The objective of this study was to explore the relationship between oral microbiota alterations and cognitive impairment in patients with SZ and to evaluate potential mediating mechanisms, including neuroinflammation and microbial functions.

Study Design

In this cross-sectional study, we recruited 68 patients with SZ and 32 healthy controls (HC). Cognitive function was assessed using the Wechsler Adult Intelligence Scale-Fourth Edition. Oral microbiota composition was characterized by 16S rRNA gene sequencing, and microbial functions were predicted using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2 (PICRUSt2) based on the 16S profiles. Neuroinflammation was assessed using peripheral kynurenine (KYN) pathway activity as a proxy.

Study Results

The patients with SZ exhibited significantly lower oral microbiota alpha diversity (driven by reduced evenness) and showed greater cognitive impairment and differences in the KYN pathway markers (neuroinflammation proxies) compared to HC. They also showed shifts in specific bacterial genera and the PICRUSt2-predicted functional pathways. Importantly, the oral microbiota alterations were significantly associated with cognitive impairment. Exploratory mediation analysis suggested that several pathways, including glycan biosynthesis and metabolism, may play a role in this association. In contrast, KYN pathway markers showed no significant association.

Conclusions

Our findings show an association between the oral microbiota alpha diversity and cognitive impairment in SZ, with the PICRUSt2-predicted functional pathways potentially implicated.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました